Poly(iohexol) Nanoparticles As Contrast Agents for in Vivo X-ray Computed Tomography Imaging

Qian Yin,Felix Y. Yap,Lichen Yin,Liang Ma,Qin Zhou,Lawrence W. Dobrucki,Timothy M. Fan,Ron C. Gaba,Jianjun Cheng
DOI: https://doi.org/10.1021/ja405196f
IF: 15
2013-01-01
Journal of the American Chemical Society
Abstract:Biocompatible poly(iohexol) nanoparticles, prepared through cross-linking of iohexol and hexamethylene diisocyanate followed by coprecipitation of the resulting cross-linked polymer with mPEG-polylactide, were utilized as contrast agents for in vivo X-ray computed tomography (CT) imaging. Compared to conventional small-molecule contrast agents, poly(iohexol) nanoparticles exhibited substantially protracted retention within the tumor bed and a 36-fold increase in CT contrast 4 h post injection, which makes it possible to acquire CT images with improved diagnosis accuracy over a broad time frame without multiple administrations.
What problem does this paper attempt to address?